160 Annual Report 2025 DIRECTORS’ INTERESTS (CONTINUED) Except as disclosed in this statement, no director who held office at the end of the financial year had interests in shares, debentures, warrants or share options of the Company, or of related corporations, either at the beginning of the financial year or at the end of the financial year. There were no changes in any of the above mentioned interests in the Company between the end of the financial year and 21 January 2026. Except as disclosed under the “Share options” and “Share awards” sections of this statement, neither at the end of, nor at any time during the financial year, was the Company a party to any arrangement whose objects are, or one of whose objects is, to enable the directors of the Company to acquire benefits by means of the acquisition of shares in or debentures of the Company or any other body corporate. SHARE OPTIONS The Employee Share Option Scheme (the “ESOS”) of the Company was approved by shareholders at an Extraordinary General Meeting of the Company on 28 September 2023. The ESOS is administered by the Company’s Remuneration Committee in consultation with the Chief Executive Officer. The ESOS will expire on 28 September 2033. The ESOS is designed to reward valuable and outstanding employees or Non-Executive Directors (excluding Independent Directors), and incentivise them to continue contributing to the long-term growth and success of the Group. Other information regarding the ESOS is set out below: Exercise of Share Options The exercise price of options shall be determined at the discretion of the Remuneration Committee on the date which the options are granted and may be set at: • A price equal to the average of the last dealt prices for the Company’s shares on SGX‑ST over the five consecutive trading days immediately preceding the date that option was granted, as determined by the Remuneration Committee by reference to the daily official list or any other publication published by the SGX‑ST, rounded to the nearest whole cent in the event of fractional prices (the “Market Price”); or • A discount to the Market Price not exceeding 20% of the Market Price (or such other percentage or amount as may be determined by the Remuneration Committee) in respect of options granted at the time of grant, provided that shareholders in general meeting have authorised, in a separate resolution, the making of offers and grants of options under the ESOS at a discount not exceeding the maximum discount as aforesaid. For the options granted with exercise price set at Market Price, they can be exercised one year from the date of the grant and will expire five years from the date of the grant. For the options granted with exercise price set at a discount to Market Price, they can be exercised two years from the date of the grant and will expire five years from the date of the grant. No options have been granted by the Company pursuant to the ESOS. DIRECTORS’ STATEMENT
RkJQdWJsaXNoZXIy NTM2MDQ5